Fig. 3
From: Molecular pathogenesis of disease progression in MLL-rearranged AML
Mutational spectrum in human MLL-AML (N = 168). A frequency of mutations (%) was shown in each affected leukemogenic pathway
Fig. 3 | Leukemia
From: Molecular pathogenesis of disease progression in MLL-rearranged AML
Mutational spectrum in human MLL-AML (N = 168). A frequency of mutations (%) was shown in each affected leukemogenic pathway
